CSS
IBIO icon

Cubist Systematic Strategies’s iBio IBIO Stock Holding History

Cubist Systematic Strategies’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-55,600
Closed -$224K – 3225
2025
Q1 		$224K Buy
+55,600
New +$216K ﹤0.01% 2479
2023
Q3 		– Sell
-795
Closed -$9.7K – 3607
2023
Q2 		$9.7K Buy
+795
New +$15K ﹤0.01% 3258
2022
Q3 		– Sell
-40
Closed -$5K – 4554
2022
Q2 		$5K Buy
+40
New +$6.01K ﹤0.01% 4298
2021
Q3 		– Sell
-33
Closed -$25K – 3050
2021
Q2 		$25K Sell
33
-45
-58% -$32.8K ﹤0.01% 2838
2021
Q1 		$60K Buy
+78
New +$68K ﹤0.01% 2716

Other funds holding IBIO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cubist Systematic Strategies's IBIO Position: Q2 2025 in Review

Cubist Systematic Strategies sold out of iBio (IBIO) in Q2 2025, closing a stake of 55,600 shares — an estimated $224K sold.

Cubist Systematic Strategies first reported a position in IBIO in Q1 2021 and held it in 5 quarters. The position peaked at $224K in Q1 2025. 30 funds tracked by Wall St. Rank hold IBIO as of Q2 2025.

  • Cubist Systematic Strategies reported no remaining iBio position as of Q2 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 55,600 iBio shares in Q2 2025, an estimated $224K.
  • Cubist Systematic Strategies first reported a position in iBio in Q1 2021 and held it in 5 quarters.
  • Cubist Systematic Strategies's iBio position peaked at $224K in Q1 2025.
  • 30 funds tracked by Wall St. Rank held iBio as of Q2 2025.

Based on Cubist Systematic Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.